Pretreatment prognostic factors of survival in patients with locally advanced nonmetastatic squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 32, Issue 2, 2009, Pages 163-168

  Jeremić, Branislav ^a,b   Miličić, Biljana ^a  

^a University Hospital   (Serbia)

^b INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

Author keywords

Chemotherapy; Head and neck cancer; Prognostic factors; Radiation therapy; Survival

Indexed keywords

CARBOPLATIN; CISPLATIN;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CARCINOMA; KARNOFSKY PERFORMANCE STATUS; LARYNX CARCINOMA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NASOPHARYNX CARCINOMA; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE;

EID: 67749091258     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31818254cc     Document Type: Article

References (50)

1. Bartelink H, Breur K, Hart G, et al. The value of postoperative radiotherapy as an adjuvant to radical neck dissection. Cancer. 1983;52:1008 -1013.
2. Huang D, Johnson CR, Schmidt-Ullrich RK, et al. Incompletely resected advanced squamous cell carcinoma of the head and neck: the effectiveness of adjuvant vs. salvage radiotherapy. Radiother Oncol. 1992;24:87-93.
3. Nisi KW, Foote RL, Bonner JA, et al. Adjuvant radiotherapy for squamous cell carcinoma of the tongue base: improved local-regional disease control compared with surgery alone. Int J Radiat Oncol Biol Phys. 1998;41:371-377.
4. Tupchong L, Scott CB, Blitzer PH, et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys. 1991;20:21-28.
5. Bernier J, Domenge C, Ozsahin M, et al. European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945-1952.
6. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937-1944.
7. Ang KK, Peters LJ, Weber RS, et al. Concomitant boost radiotherapy schedule in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys. 1990;19:1339-1345.
8. Cox JD, Pajak TF, Marcial VA, et al. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of Radiation Therapy Oncology Group, protocol 83-13. Int J Radiat Oncol Biol Phys. 1990;18:515-521.
9. Dische S, Saunders M, Barrett A, et al. A randomized multicentre trial of CHART versus conventional radiotherapy in head and neck. Radiother Oncol. 1997;44:123-136.
10. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7-16.
11. Horiot J-C, Bontemps P, van der Bogaert W, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol. 1997;44:111-121.
12. Adelstein DJ, Sexton JP, Lavertu P, et al. A phase III randomized trial comparing concurrent radiotherapy alone in resectable stage III and IV squmaous cell head and neck cancer: preliminary results. Head Neck. 1997; 19:567-575.
13. Budach V, Stuschke M, Budach W, et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol. 2005;23:1125-1135.
14. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. New Engl J Med. 1998;338:1798-1804.
15. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91:2081-2086.
16. Jeremic B, Shibamoto Y, Stanisavljevic B, et al. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother Oncol. 1997;43:29-37.
17. Jeremic B, Shibamoto Y, Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent low-dose cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol. 2000;18:1458-1464.
18. Wendt TG, Grabenbauer GG, Rodel CM, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol. 1998;16:1318-1324.
19. Bourhis J, Amand C, Pignon J-P, MACH-NC Collaborative Group. Update of MACH-NC (Meta-Analysis of Chemotherapy in Head and Neck Cancer) database focused on concomitant chemoradiotherapy. J Clin Oncol. 2004; 22(suppl 14):5505.
20. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet. 2000;355:949-955.
21. Bourhis J, Overgaard J, Audry H, et al. Meta-analysis of radiotherapy in carcinomas of head and neck (MARCH) collaborative group. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. 2006;368:843-854.
22. Glatstein E, Makuch RW. Illusion and reality: practical pitfalls in interpreting clinical trials. J Clin Oncol. 1984;2:488-497.
23. Simon R. Importance of prognostic factors in cancer clinical trials. Cancer Treat Rep. 1984;68:185-192.
24. Curran WJ Jr, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993;85:704 -710.
25. Cooper JS, Farnan NC, Asbell SO, et al. Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer. Cancer. 1996;77:1905-1911.
26. Johansen LV, Grau C, Overgaard J. Hypopharyngeal squamous cell carcinoma. Treatment results in 138 consecutively admitted patients. Acta Oncol. 2000;39:529-536.
27. Daly T, Poulsen MG, Denham JW, et al. The effect of anemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 2003;68:113-122.
28. Denis F, Garaud P, Bardet E, et al. Final results of the 94 - 01 French head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004;22:69-76.
29. Lee RW, Berkey B, Marcial V, et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys. 1998;42:1069-1075.
30. Prosnitz RG, Yao B, Farrell CL, et al. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 2005;61:1087-1095.
31. Jeremic B, Milicic B, Dagovic A, et al. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck. J Clin Oncol. 2004;22:3540-3548.
32. de Jong RJB, Hermans J, Molenaar J, et al. Prediction of survival in patients with head and neck cancer. Head Neck. 2001;23:718-724.
33. Johansen LV, Grau C, Overgaard J. Squamous cell carcinoma of the oro-pharynx. An analysis of treatment results in 289 consecutively admitted patients. Acta Oncol. 2000;39:985-994.
34. Perez CA, Patel M, Chao K. Carcinoma of the tonsillar fossa: prognostic factors and long term therapy outcome. Int J Radiat Oncol Biol Phys. 1998;42:1077-1084.
35. Cerezo L, Millan I, Torre A, et al. Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate analysis of 492 cases. Cancer. 1992;69:1224 -1234.
36. Chua DT, Shan J, Kwong D. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys. 1997;39:711-719.
37. Grabenbauer GG, Steininger H, Meyer M, et al. Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer. Radiother Oncol. 1998;47:175-183.
38. Hermans R, Op de Beck K, Van den Bogaert W, et al. The relation of CT-determined tumor parameters and local and regional outcome of tonsillar cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys. 2001;50:37-45.
39. Nathu RM, Mancuso A, Zhu T. The impact of primary tumor volume on local control for oropharyngeal squamous cell carcinoma treated with radiotherapy. Head Neck. 2000;22:1-5.
40. Pameijer FA, Mancuso A, Mendenhall W. Can pre-treatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys. 1997;37:1011-1021.
41. Pameijer FA, Mancuso A, Mendenhall W. Evaluation of pre-treatment computed tomography as a predictor of local control in T1/T2 pyriform sinus carcinoma treated with definitive radiotherapy. Head Neck. 1998;20:159-168.
42. Plataniotis GA, Theofanopoulou M-E, Kalogera-Fountzila A, et al. Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial. Int J Radiat Oncol Biol Phys. 2004;59:1018-1026.
43. Doweck I, Denys D, Robins KT. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted radiochemotherapy. Laryngoscope. 2002;112:1742-1749.
44. Rudat V, Dietz A, Schramm O, et al. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiother Oncol. 1999;53:119 -125.
45. Johansen LV, Grau C, Overgaard J. Squamous cell carcinoma of the nasopharynx. An analysis of treatment results in 149 consecutively admitted patients. Acta Oncol. 2001;40:801-809.
46. Bourhis J, Le Maître A, Pignon J, Ang K, et al. Impact of age on treatment effect in locally advanced head and neck cancer (HNC): two individual patient data meta-analyses. J Clin Oncol. 2006;24(suppl 18):5501.
47. O'Sullivan B, Shah J. New TNM staging criteria for head and neck tumors. Semin Surg Oncol. 2003;21:30-42.
48. Adelstein DJ, Lavertu P, Saxton JP, et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer. 2000;88:876-883.
49. Jaulerry C, Dubray B, Brunin F, et al. Prognostic value of tumor regression during radiotherapy for head and neck cancer: A prospective study. Int J Radiat Oncol Biol Phys. 1995;33:271-279.
50. Jeremic B, Milicic B. Pretreatment prognostic factors of local recurrence-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. Am J Clin Oncol. 2008;31:213-218.